These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34359799)

  • 21. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.
    Bareau B; Rey J; Hamidou M; Donadieu J; Morcet J; Reman O; Schleinitz N; Tournilhac O; Roussel M; Fest T; Lamy T
    Haematologica; 2010 Sep; 95(9):1534-41. PubMed ID: 20378561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
    Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease.
    Zawit M; Bahaj W; Gurnari C; Maciejewski J
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
    Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
    Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and treatment outcomes of Asian patients with T-cell large granular lymphocytic Leukemia: a single-center analysis of 67 cases.
    Park T; Byun JM; Shin DY; Koh Y; Hong J; Yoon SS; Chang YH; Kim I
    Ann Hematol; 2024 Apr; 103(4):1235-1240. PubMed ID: 38062223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a Better Classification System for NK-LGL Disorders.
    Drillet G; Pastoret C; Moignet A; Lamy T; Marchand T
    Front Oncol; 2022; 12():821382. PubMed ID: 35178350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
    Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
    Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large granular lymphocytic leukemia - A retrospective study of 319 cases.
    Dong N; Castillo Tokumori F; Isenalumhe L; Zhang Y; Tandon A; Knepper TC; Mo Q; Shao H; Zhang L; Sokol L
    Am J Hematol; 2021 Jul; 96(7):772-780. PubMed ID: 33819354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.
    Calabretto G; Teramo A; Barilà G; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
    Barilà G; Grassi A; Cheon H; Teramo A; Calabretto G; Chahal J; Vicenzetto C; Almeida J; Shemo BC; Shi M; Gasparini VR; Munoz-Garcia N; Pastoret C; Nakazawa H; Oshimi K; Sokol L; Ishida F; Lamy T; Orfao A; Morice WG; Loughran TP; Semenzato G; Zambello R
    Blood; 2023 Mar; 141(9):1036-1046. PubMed ID: 36096473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical characteristics of T-cell large granular lymphoblastic leukemia with STAT3 gene mutation].
    Liu HL; Cao L; Zhao XL; Guo JJ; Qiao C; Zhu HY; Wang L; Xu W; Li JY; Fan L
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):495-501. PubMed ID: 34384156
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatic
    Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
    Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complex relationship between large granular lymphocyte leukemia and rheumatic disease.
    Marchand T; Lamy T
    Expert Rev Clin Immunol; 2024 Mar; 20(3):291-303. PubMed ID: 38105745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
    Qiu ZY; Fan L; Wang L; Qiao C; Wu YJ; Zhou JF; Xu W; Li JY
    J Hematol Oncol; 2013 Oct; 6():82. PubMed ID: 24283217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders.
    Drillet G; Pastoret C; Moignet A; Lamy T; Marchand T
    Rev Med Interne; 2023 Jun; 44(6):295-306. PubMed ID: 37087371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment.
    Ullah F; Markouli M; Orland M; Ogbue O; Dima D; Omar N; Mustafa Ali MK
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
    Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
    Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a
    Mariotti B; Calabretto G; Rossato M; Teramo A; Castellucci M; Barilà G; Leoncin M; Vicenzetto C; Facco M; Semenzato G; Bazzoni F; Zambello R
    Haematologica; 2020 May; 105(5):1351-1360. PubMed ID: 31467122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Large granular lymphocyte leukemia: clinical and pathogenic aspects].
    Lazaro E; Duffau P; Chaigne Delalande S; Greib C; Pellegrin JL; Viallard JF
    Rev Med Interne; 2013 Sep; 34(9):553-60. PubMed ID: 23928096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
    Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
    Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.